Get startedLog in
    Picture of Protara Therapeutics logo

    TARA — Protara Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Protara Therapeutics Inc Reports Q3 Loss Per Share Of $0.68

    Picture of Protara Therapeutics logoProtara Therapeutics
    03/11/2022 12:32
    Nov 3 (Reuters) - Protara Therapeutics Inc  TARA.O :
    * PROTARA THERAPEUTICS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS OVERVIEW
    * PROTARA THERAPEUTICS INC Q3 LOSS PER SHARE $0.68
    * PROTARA THERAPEUTICS INC- STRONG CASH, CASH EQUIVALENTS
AND
INVESTMENTS POSITION OF $107.1 MILLION AS OF SEPTEMBER 30, 2022
    * PROTARA THERAPEUTICS INC- NOW EXPECTED TO FUND OPERATIONS
INTO
2H2024
    * PROTARA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.68

Source text for Eikon:  ID:nGNX9HfZTn 
Further company coverage:  TARA.O 
 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Protara Therapeutics

    See all news